Segment Reporting - Summary of Financial Information with Respect to Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Segment revenues:
Total revenues	$ 35,189	$ 38,469	$ 99,971	$ 87,132
Segment gross profit:
Total segment gross profit	13,810	17,134	59,503	45,117
Unallocated:
Research and development	(42,705)	(31,123)	(83,446)	(58,945)
Sales and marketing	(9,022)	(7,428)	(18,167)	(14,099)
General and administrative	(23,216)	(22,056)	(49,524)	(44,189)
Gain on equity investments	0	11,828	147,322	11,828
Change in fair value	40,654	(15,700)	76,391	(21,864)
Other income (expense)	4,326	(308)	7,263	31
Income tax benefit (expense)	20,431	(33)	(5,928)	(5)
Consolidated net income (loss)	4,278	(47,686)	133,414	(82,126)
Operating Segments | Software
Segment revenues:
Total revenues	29,352	30,011	61,565	63,092
Segment gross profit:
Total segment gross profit	22,657	22,910	47,755	48,480
Operating Segments | Drug discovery
Segment revenues:
Total revenues	5,837	8,458	38,406	24,040
Segment gross profit:
Total segment gross profit	$ (8,847)	$ (5,776)	$ 11,748	$ (3,363)